All News

Even if care teams have all of your information on their end, advocating for yourself is still necessary during cancer treatment.

Patients with cervical cancer demonstrated better sexual health and quality of life after undergoing simple hysterectomies versus radical hysterectomies.

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.

Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in early data from a phase 3 trial.

Perioperative chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) shows promising long-term benefits with minimal side effects.

I once thought that prostate cancer should be the center of my universe, but with everything else going on, now I’m not so sure.

Among patients with polycythemia vera, the treatment pairing of Jakafi and Pegasys shows benefits with acceptable toxicity, research showed.

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

A colleague wrote about a dedicated oncology nurse who excels in patient care, demonstrates exceptional clinical skills and consistently goes above and beyond to improve patient outcomes.

I initially put off a colonoscopy due to gastroesophageal reflux disease, but after a positive home screening test, I underwent the procedure and was diagnosed with stage 3 rectal cancer.

The FDA received the New Drug Application for avutometinib plus defactinib as a potential treatment option for previously treated low-grade serous ovarian cancer.

During October, the FDA approved drugs to treat diseases including breast cancer, lung cancer, leukemia and gastric cancer.

After my breast cancer diagnosis, I decided to take a more active role in my treatment plan, opting for radiation therapy over chemotherapy due to concerns about side effects.

From World Series tickets given to a pediatric patient with cancer to the death of David Harris, known as Cochise in “The Warriors,” at the age of 75, here is this week’s cancer news.

In the first 15 patients, radiofrequency ablation was shown to reduce pain scores in most patients with pancreatic cancer.

Three phase 3 trials will assess datopotamab deruxtecan-based treatments in patients with nonsquamous non-small cell lung cancer.

Patients with resected stage 3 or 4 melanoma treated with immune-oncology agents demonstrated significantly higher cure rates compared to those treated with placebo.

Preoccupied with other worries during October, a month full of cancer anniversaries, I reflect on how Pinktober caught up with me.

Second-line treatment with Inrebic has been shown to be beneficial for patients with myelofibrosis previously treated with Jakafi.

The agency is alerting patients and providers to not use the implantable devices, made for soft tissue such as breast tissue.

In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to learn more about how patients with breast cancer can connect with each other.

CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center for a webinar to discuss the importance of self-advocacy.

In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to discuss supporting others with breast cancer.

Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients with renal cell carcinoma.

My daughter faced the difficult decision of balancing the potential benefits and risks of cancer treatment, including the long-term heart complications associated with Herceptin.

Treatment containing Recentin demonstrated clinical benefits, but it proves worse than the current standard care treatment.

An expert discussed how patients with breast cancer, particularly those with a BRCA mutation, should consider future fertility and breastfeeding when making treatment decisions.

A phase 2 clinical trial of a new brain cancer treatment is underway.